Homework answers / question archive / University of Illinois, Chicago NURS 531 Chapter 23: Atherosclerosis and lipoprotein metabolism MULTIPLE CHOICE 1)Activation of the peroxisome proliferator-activated receptor-alpha is produced by administration of   ezetimibe fenofibrate simvastatin niacin colesevelam     2

University of Illinois, Chicago NURS 531 Chapter 23: Atherosclerosis and lipoprotein metabolism MULTIPLE CHOICE 1)Activation of the peroxisome proliferator-activated receptor-alpha is produced by administration of   ezetimibe fenofibrate simvastatin niacin colesevelam     2

Nursing

Share With

---

 

 

3.    Myositis leading to rhabdomyolysis is a potentially severe adverse effect of

 

1. atorvastatin
2. niacin
3. colestipol
4. ezetimibe
5. cholestyramine

 

4.    Increased expression of apoproteins A-I and A-II occurs in persons receiving

 

1. colestipol
2. niacin
3. simvastatin
4. ezetimibe
5. gemfibrozil

 

 

5.    Simvastatin and related drugs have been shown to reduce mortality in persons with

 

1. hypertriglyceridemia
2. low HDL-cholesterol levels
3. an inability to make LDL receptors
4. symptomatic coronary artery disease
5. myositis

 

 

6.    Which drug inhibits hepatic triglyceride synthesis and VLDL secretion?

 

1. fenofibrate
2. colestipol
3. niacin
4. ezetimibe
5. atorvastatin